Prime Medicine, Inc. (PRME)
NASDAQ
Closed
Sep 18, 2026
Day's Range
3.0452 wk Range
2.67Profile - PRME - Prime Medicine, Inc.
Profile
Mic Code
XNMS
Sector
Healthcare
Industry
Biotechnology
Employees
146
Prime Medicine, Inc. is a biotechnology company focused on developing genetic medicines through its Prime Editing platform, a gene-editing technology designed to make precise changes to DNA. The company is building therapies intended to address diseases caused by defined genetic alterations, with research programs spanning hematology, immunology and oncology, liver, lung, ocular, and neuromuscular conditions. Its current work centers on investigational, pre-commercial product candidates and platform capabilities that support targeted genetic correction across multiple tissues and disease areas. Prime Medicine, Inc. plays a specialized role in the broader genetic medicines market by advancing next-generation editing approaches aimed at expanding the reach of precision therapeutics for serious inherited and acquired diseases.
Profile Details
Type
Common Stock
Address
60 First Street
City
Cambridge
State
MA
Zip
02141
Country
United States
Phone
617 465 0013
Key Executives - PRME - Prime Medicine, Inc.
Key executives
Cross Listings - PRME - Prime Medicine, Inc.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
